We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Spectroscopy Technique Improves Surgery for Pediatric Epilepsy Patients

By LabMedica International staff writers
Posted on 12 Mar 2025

Epilepsy affects over 50 million people globally, with approximately half of them being children. More...

For about one-third of these patients, seizures remain uncontrolled by medications, making surgery the only viable option to provide relief. In 60% of these drug-resistant cases, seizures originate from a specific region of the brain, making surgical removal of the affected tissue the most effective treatment. The most common cause of focal epilepsy in children is focal cortical dysplasia (FCD), with type II being the most prevalent. However, accurately identifying the epileptogenic zone (EZ) during surgery can be challenging, complicating the overall success of the procedure.

A new study offers a promising approach to improving surgical precision through the use of Raman spectroscopy, a non-invasive technique that analyzes the chemical composition of tissues. The collaborative study, conducted by researchers from Polytechnique Montréal (Quebec, Canada), applied Raman microspectroscopy to tissue samples from pediatric patients diagnosed with FCD type II. By examining the biochemical signatures of individual cells, the researchers successfully distinguished abnormal FCD tissue from healthy brain cells with remarkable accuracy. The method was able to identify FCD tissue with 96% accuracy and differentiate between two subtypes of FCD type II with 92% accuracy.

These findings, published in Biophotonics Discovery, suggest that Raman spectroscopy, when used during surgery with a fiber optics system, could provide real-time guidance for surgeons to accurately identify and remove only the affected tissue, preserving healthy brain areas. In addition to improving surgical outcomes, the technique offers valuable insights into the biochemical changes that may contribute to the development of epilepsy. This innovative approach could ultimately improve seizure control and surgical success in children suffering from drug-resistant epilepsy.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automatic CLIA Analyzer
Shine i6000
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers combined a blood-based biomarker of Alzheimer’s disease with age, sex, and genetic risk to estimate future cognitive impairment risk in asymptomatic adults (Image Credit: Adobe Stock)

Blood Biomarker Model May Help Estimate Five- and 10-Year Cognitive Impairment Risk

Estimating future cognitive impairment risk remains challenging in cognitively healthy adults, particularly when biomarker findings are reduced to simple positive or negative results. Because mild cognitive... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Lung Cancer Atlas Reveals Cellular Patterns Associated With Patient Prognosis

Lung cancer is a leading cause of cancer-related death worldwide and is characterized by substantial cellular heterogeneity. Even within a single tumor, cancer cells can vary in aggressiveness, while immune,... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Malaria is caused by Plasmodium parasites, primarily transmitted through the bites of infected female Anopheles mosquitoes (Image Credit: Adobe Stock)

Complete Malaria Genomes Could Improve Species Identification and Surveillance

Malaria remains a major global health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. Although most research has focused on Plasmodium falciparum, Plasmodium ovale... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.